Navigation Links
Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers'
Date:5/16/2008

NUTLEY, N.J., May 16 /PRNewswire/ -- Barbara Senich, B.S.N., M.B.A., M.P.H., Roche vice president, Sales and Marketing Services, was honored by Executive Women of New Jersey (EWNJ) at its "Salute to the Policy Makers" 2008 Awards Dinner. The biennial event, held May 15, 2008 at the Hyatt Regency New Brunswick, recognized women of professional distinction in New Jersey who are senior executives or members of boards of directors at major New Jersey-based corporations and organizations.

"Barbara is extremely deserving of this honor. As a member of Roche senior management, she participates in all areas of corporate decision making. Her knowledge, experience and leadership are instrumental in helping Roche build a world class organization that effectively serves the needs of the healthcare community as well as the patients whose lives are improved by our medicines," said George Abercrombie, president and CEO of Hoffmann-La Roche Inc.

"Over the course of the last two decades, the Salute to the Policy Makers Awards Dinner has evolved into a 'Hall of Fame' of sorts for accomplished women throughout the Garden State and we are pleased to include Barbara Senich among the 36 women honored this year," added EWNJ President-Elect and 2008 Salute Dinner Chair Mary S. Hartman, Ph.D., who also serves as director of the Institute for Women's Leadership at Rutgers University.

Senich, who joined Roche in 2004 in her current position, has extensive experience in the pharmaceutical industry, especially in the areas of managed care, pricing, market research and product marketing. She leads a multifunctional area of eight departments including the Transplant Therapeutic area, Account Management and others that provide critical strategic and analytical support to the company's commercial operations.

Senich began her career in the pharmaceutical industry as a sales representative and held a number of increasingly responsible marketing and sales positions be
'/>"/>

SOURCE Roche Public Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Roche Symposium Showcases Accomplishments of Next Generation of Chemists
2. Roches Vidal Honored as 2008 HBA Rising Star
3. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
4. Media advisory - Neurochems Annual and Special Meeting of Shareholders April 15, 2008
5. Neurochem Annual and Special Meeting of shareholders
6. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
7. Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
8. Roche Statement Regarding Tamiflu U.S. Label Revision
9. Neurochem announces departure of two members of management team
10. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
11. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 Dr. Kwame Bawuah ... the workshop with an admonition to the youth to ... in life. He also advised the youth to stay ... sex. He said, “This workshop will afford you the ... you to withstand the storms in your career path.” ...
(Date:7/24/2014)... 24, 2014 The first-ever successful isolation ... patient’s blood has been achieved by NFCR-supported scientist Daniel ... Hospital. This is an important milestone on the road ... the best treatment for each patient. , “Tumors ... often acquire new genetic features that make them resistant ...
(Date:7/24/2014)... the patient or their tumor more directly to ionizing ... damages the cancer cells irreparably. Unfortunately, such radiation is ... the site of the tumor, which is then at ... cancer. As such finding ways to protect the overlying ... Journal of Low Radiation, Faruck Lukmanul Hakkim of the ...
(Date:7/24/2014)... have uncovered a way the malaria parasite becomes ... Washington University School of Medicine in St. Louis, ... bacterial infections and tuberculosis. , The study appears ... Many organisms, including the parasite that causes malaria, ... play multiple roles in keeping organisms healthy, whether ...
(Date:7/24/2014)... Charlotte, NC (PRWEB) July 24, 2014 ... donated over $138,000 in sealant and anesthesia reversal ... ToothFairy® (NCOHF) to help save young smiles. The ... Sealant Kits and Oraverse® was distributed to America’s ... the U.S. with vital oral health services. The ...
Breaking Medicine News(10 mins):Health News:Youth and Professionals Interact at Washington Metro Area Career Workshop Hosted by the Edusei Foundation 2Health News:New Blood Test Advances Individualized Cancer Therapy and Cuts Down on Need for Painful Biopsies 2Health News:Natural products from plants protect skin during cancer radiotherapy 2Health News:One route to malaria drug resistance found 2Health News:One route to malaria drug resistance found 3Health News:Septodont Donation Helps Children in Need 2
... responsible for a form of the herpes virus that causes ... causes purple skin blotches and can also attack the internal ... disease defenses but attacks those with weakened immune system as ... 8 was discovered six years ago. Almost 30% to 50% ...
... not reduce ,the risk of cardiac events ... disease (CAD). In the PHASE trial (Papworth ... women with angiographically proven coronary ,artery disease ... without cyclic norethisterone--or no hormone replacement therapy. ...
... Lunelle-a monthly injectable contraceptive pill has been approved by ... is more than 99 percent effective when women get ... release marketing the pill., ,Lunelle is an alternative ... months. It works Like many other birth control pills ...
... overall long-term survival rates in both men and women. Their ... ,Researchers studied survival rates based on a lung function ... the lung function test on a group of more than ... age from 20 to 89 years at enrollment. They have ...
... In some of the cancer patients the Tumors can't be ... using vitamin B12 that helps doctors locate hard to find ... vitamin B12. After three hours a gamma camera takes pictures ... cancer and he says that, "The cancer stands out as ...
... The American Heart Association announced it has revised ... of ,cardiovascular emergencies., ,Untrained bystanders and CPR-certified ... an unconscious person's pulse before administering chest compressions. ... breath, movement and response to stimulation as indicators. ...
Cached Medicine News:
(Date:7/24/2014)... -- Decision Resources Group finds that, for the treatment ... France , Germany , ... and the United Kingdom ) hold ... beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), Relvar (GlaxoSmithKline/Theravance). ... first-line LABA/ICS FDC in the treatment of asthma with ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- "North America ... key market data on the North America Orthopedic Braces ... of US dollars, and volume (in units) and average ... , Knee Braces and Supports , Ankle ... , Upper Extremities Braces and Supports. ...
(Date:7/24/2014)... 24, 2014 Boston Children,s Hospital,s Global Pediatric ... will feature an "Innovation Tank" – a forum designed ... pitch their business or product solution to a panel ... on how to accelerate the innovation and bring it ... of Friday, October 31, will be moderated by ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3
... 2011 /PRNewswire-Asia-FirstCall/ -- Financial Highlights for the ... increased 40.8% to $7.68 million Gross profit increased 30.1% to ... 14.2% to $3.90 million, representing a net margin of 50.8% ... Financial Highlights for the Six Months Ended June ...
... Mylan Inc. (Nasdaq: MYL ) today announced that ... Tablets, 10 mg. This product is the generic version of ... hyperplasia, or an enlarged prostate. Uroxatral® Tablets ... months ending June 30, 2011, according to IMS Health. ...
Cached Medicine Technology:Nutrastar Announces Second Quarter 2011 Financial Results 2Nutrastar Announces Second Quarter 2011 Financial Results 3Nutrastar Announces Second Quarter 2011 Financial Results 4Nutrastar Announces Second Quarter 2011 Financial Results 5Nutrastar Announces Second Quarter 2011 Financial Results 6Nutrastar Announces Second Quarter 2011 Financial Results 7Nutrastar Announces Second Quarter 2011 Financial Results 8Nutrastar Announces Second Quarter 2011 Financial Results 9Nutrastar Announces Second Quarter 2011 Financial Results 10Nutrastar Announces Second Quarter 2011 Financial Results 11
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: